Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.
about
Translatability scoring in drug development: eight case studiesAnimal models of hemophiliaLessons Learned from Animal Models of Inherited Bleeding Disorders.A review of current methods for assessing hemostasis in vivo and introduction to a potential alternative approach.Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency.Real-time electrical impedimetric monitoring of blood coagulation process under temperature and hematocrit variations conducted in a microfluidic chip.Helper-dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia A model.Von Willebrand syndrome induced by a Bothrops venom factor: bioassay for venom coagglutininPreservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusionEffect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand diseaseThe thrombotic activity of activation productStudies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedentThe relationship between factor XI coagulant and factor XI antigenic activity in cattleFibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.The kaolin clotting time; a rapid one-stage method for diagnosis of coagulation defects.The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8.Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factorFunction of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimerasThe defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.The plasma hemostatic proteome: thrombin generation in healthy individuals.Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragmentTissue factor activity in lymphocyte cultures from normal individuals and patients with hemophilia AEffects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.Abnormal factor VIII coagulant antigen in patients with renal dysfunction and in those with disseminated intravascular coagulation.Christmas disease in one of a pair of monozygotic twin girls, possibly the effect of lyonization.Plasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand FactorsProtein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.Antibody nature of circulating inhibitor of plasma von Willebrand factor.In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.Factor VIII recombination after dissociation by CaCl12.The phenotypic range of hemophilia A carriers.Biochemical genetics of blood coagulation.Congenital dysfibrinogenemia: fibrinogen DetroitEnzymes and blood clotting. I. Trypsin as an accessory factorSome methods for in vitro estimation of the blood compatibility of biomaterials.Clinical practice: the bleeding child. Part II: disorders of secondary hemostasis and fibrinolysis.The value of animal models.Effects of certain purified plasma proteins on the compatibility of glass with bloodExperimental interactions of components of hemodialysis units with human blood
P2860
Q22241760-1CBFE76E-8747-4D8D-8207-15DB5B393530Q27012571-A7F74412-4F67-4E9E-952C-6CC8D5A22ADEQ30409863-E9CCAE15-9EEF-4D27-8A70-CC51D48B57E8Q30442996-76FE1666-1F91-4F3C-98E6-83CFDBB08450Q30448556-FF0E4113-F866-4226-9046-4F75B6912326Q31141659-4DD1FF3E-3467-46EB-89C4-9AD51CE75100Q33371228-8A525458-DA8D-4CD7-A430-1243D02D11ADQ33481585-6034B5B8-9E3F-44FF-B106-39012E5617A6Q33490246-F3C58356-068C-45B2-98AA-785B046D04C9Q33838757-9BA8323D-B6CF-4135-BC03-FA593C1B96AAQ33941226-86EEAB8E-2809-49B1-B154-C12E96F3A06AQ34011088-68737892-3731-4379-B540-5944FFD38DCCQ34046061-0F39ED90-DF15-4A54-8801-0074215C376DQ34063620-4239D28F-6727-4E32-9488-1E1F11EEF00FQ34244473-1E13C7C6-E49F-416A-8F41-BB6954488566Q34266673-822A0DD0-A113-4E48-A664-BDB1AA60535AQ34272309-88C27AD4-6106-495D-8D95-FCAEB91876DCQ34366855-64CFE75B-DEB6-4BC4-99A4-2A92FC62EB5BQ34468951-BDB56FD6-4462-4CF4-9644-0238BD32DC88Q34469121-C12899A7-5308-44FB-BAFC-1FBA041D6D74Q34481022-06F6AC04-7DA3-4199-970C-C3254F4DE8DEQ34482160-32E3E8EF-65AD-497A-BA72-B6946472F272Q34505773-C2235768-52A3-469E-BED8-35903ABA8DCCQ34543322-57E918C6-AFAE-480A-82AA-5D8569784E2EQ34558684-87A9406F-82CE-4BAD-91EB-3B38702ED03CQ34634494-72A4261C-C8B9-43D7-97E7-3F627BCB58DFQ34737319-E5A2E728-1C30-4DD8-B777-9444513AAD9AQ35006603-FE19CA60-A18A-4878-8C1E-7025FC61023FQ35092624-2106084D-41FC-4009-9A3A-0915C21496F8Q35109095-94F7CE29-1B7C-4C6B-84DF-385B14D711ECQ35110177-1AAA77FE-A766-4B7B-8A06-578FE27E3812Q35201629-09FCEAE9-5E07-4EA7-8E17-722EADBD3C9CQ35252818-77391417-C1D6-45E2-BD48-8D79A996209BQ35567541-EFB27D20-9E7C-471B-9DFF-C7A7F5E40025Q35568062-5DCDD63C-471C-45F2-B383-A8CD40880660Q35655154-0BEE8096-F1B9-4D7C-A840-1104345E25F4Q35672990-36F6992A-DE50-46DE-A73A-013E266D187EQ35863534-B333A2BE-4706-4A0D-BC00-288D99F62F63Q35864754-D9817DA0-EDE3-44AA-9E61-0E71CE2D930DQ35875289-7C29C9B7-6DC8-4980-8410-EF65BD241374
P2860
Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.
description
1953 nî lūn-bûn
@nan
1953 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1953 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1953年の論文
@ja
1953年論文
@yue
1953年論文
@zh-hant
1953年論文
@zh-hk
1953年論文
@zh-mo
1953年論文
@zh-tw
1953年论文
@wuu
name
Effect of antihemophilic facto ...... ophilic factor assy procedure.
@ast
Effect of antihemophilic facto ...... ophilic factor assy procedure.
@en
Effect of antihemophilic facto ...... ophilic factor assy procedure.
@nl
type
label
Effect of antihemophilic facto ...... ophilic factor assy procedure.
@ast
Effect of antihemophilic facto ...... ophilic factor assy procedure.
@en
Effect of antihemophilic facto ...... ophilic factor assy procedure.
@nl
prefLabel
Effect of antihemophilic facto ...... ophilic factor assy procedure.
@ast
Effect of antihemophilic facto ...... ophilic factor assy procedure.
@en
Effect of antihemophilic facto ...... ophilic factor assy procedure.
@nl
P2093
P1476
Effect of antihemophilic facto ...... ophilic factor assy procedure.
@en
P2093
BRINKHOUS KM
LANGDELL RD
P304
P577
1953-04-01T00:00:00Z